journal article·2024-01Open access

Extracellular Vesicles in Infrapatellar Fat Pad from Osteoarthritis Patients Impair Cartilage Metabolism and Induce Senescence

Yumei Cao, Jianzhao Ruan, Jingliang Kang, Xiaoyu Nie, Weiren Lan, Guangfeng Ruan, Jia Li, Zhaohua Zhu, Weiyu Han, Su'an Tang, Changhai Ding

Advanced Science· Volume 11· Issue 3

Abstract

Abstract Infrapatellar fat pad (IPFP) is closely associated with the development and progression of knee osteoarthritis (OA), but the underlying mechanism remains unclear. Here, it is find that IPFP from OA patients can secret small extracellular vesicles (sEVs) and deliver them into articular chondrocytes. Inhibition the release of endogenous osteoarthritic IPFP‐sEVs by GW4869 significantly alleviated IPFP‐sEVs‐induced cartilage destruction. Functional assays in vitro demonstrated that IPFP‐sEVs significantly promoted chondrocyte extracellular matrix (ECM) catabolism and induced cellular senescence. It is further demonstrated that IPFP‐sEVs induced ECM degradation in human and mice cartilage explants and aggravated the progression of experimental OA in mice. Mechanistically, highly enriched let‐7b‐5p and let‐7c‐5p in IPFP‐sEVs are essential to mediate detrimental effects by directly decreasing senescence negative regulator, lamin B receptor (LBR). Notably, intra‐articular injection of antagomirs inhibiting let‐7b‐5p and let‐7c‐5p in mice increased LBR expression, suppressed chondrocyte senescence and ameliorated the progression of experimental OA model. This study uncovers the function and mechanism of the IPFP‐sEVs in the progression of OA. Targeting IPFP‐sEVs cargoes of let‐7b‐5p and let‐7c‐5p can provide a potential strategy for OA therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Clinical Research Centre Zhujiang Hospital Southern Medical University Guangzhou Guangdong 510260 China

Department of Rheumatology and Immunology Zhujiang Hospital Southern Medical University Guangzhou Guangdong 510260 China

Clinical Research Centre Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou 510180 China

Division of Orthopaedic Surgery Department of Orthopedics Nanfang Hospital Southern Medical University Guangzhou Guangdong 510515 China

Centre of Orthopedics Zhujiang Hospital Southern Medical University Guangzhou Guangdong 510260 China

Menzies Institute for Medical Research University of Tasmania Hobart Tasmania 7000 Australia

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (46)

Show source-provided references
1. 10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
2. 10.1016/j.joca.2020.11.00310.1016/j.joca.2020.11.003 ↗
3. 10.1016/j.joca.2021.10.00310.1016/j.joca.2021.10.003 ↗
4. 10.1038/s41584-020-0407-310.1038/s41584-020-0407-3 ↗
5. 10.14336/AD.2019.111610.14336/AD.2019.1116 ↗
6. 10.1186/ar460710.1186/ar4607 ↗
7. 10.1007/s00264-015-2707-910.1007/s00264-015-2707-9 ↗
8. 10.1136/annrheumdis-2011-20068810.1136/annrheumdis-2011-200688 ↗
9. 10.1136/ard.2010.14004610.1136/ard.2010.140046 ↗
10. 10.1186/s12943-021-01365-z10.1186/s12943-021-01365-z ↗
11. 10.1016/j.ymthe.2021.03.01510.1016/j.ymthe.2021.03.015 ↗
12. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
13. 10.1016/j.celrep.2021.11027710.1016/j.celrep.2021.110277 ↗
14. 10.1016/j.cell.2016.01.04310.1016/j.cell.2016.01.043 ↗
15. 10.1038/s41556-018-0250-910.1038/s41556-018-0250-9 ↗
16. 10.1186/s12943-019-0991-510.1186/s12943-019-0991-5 ↗
17. 10.1016/j.cell.2019.02.02910.1016/j.cell.2019.02.029 ↗
18. 10.1002/jev2.1200210.1002/jev2.12002 ↗
19. 10.1186/ar467910.1186/ar4679 ↗
20. 10.1016/j.intimp.2022.10913510.1016/j.intimp.2022.109135 ↗
21. 10.1016/j.tibs.2020.03.00810.1016/j.tibs.2020.03.008 ↗
22. 10.1038/nrrheum.2016.6510.1038/nrrheum.2016.65 ↗
23. 10.1111/acel.1256210.1111/acel.12562 ↗
24. 10.1172/JCI9514710.1172/JCI95147 ↗
25. 10.1016/j.stemcr.2022.02.01210.1016/j.stemcr.2022.02.012 ↗
26. 10.1002/2211-5463.1277510.1002/2211-5463.12775 ↗
27. 10.1016/j.mad.2019.01.00110.1016/j.mad.2019.01.001 ↗
28. 10.1038/s41413-021-00183-910.1038/s41413-021-00183-9 ↗
29. 10.1186/s13287-019-1193-110.1186/s13287-019-1193-1 ↗
30. 10.1007/s00011-021-01503-910.1007/s00011-021-01503-9 ↗
31. 10.1146/annurev-cellbio-101512-12232610.1146/annurev-cellbio-101512-122326 ↗
32. 10.1093/nar/gkz87910.1093/nar/gkz879 ↗
33. 10.1016/j.cell.2009.01.03510.1016/j.cell.2009.01.035 ↗
34. 10.7150/thno.1713310.7150/thno.17133 ↗
35. 10.1002/jev2.1205610.1002/jev2.12056 ↗
36. 10.1186/s13287-018-1004-010.1186/s13287-018-1004-0 ↗
37. 10.1002/jev2.1215210.1002/jev2.12152 ↗
38. 10.3389/fmolb.2021.76611510.3389/fmolb.2021.766115 ↗
39. 10.18632/aging.20320110.18632/aging.203201 ↗
40. 10.1016/j.bbi.2015.04.01410.1016/j.bbi.2015.04.014 ↗
41. 10.1186/s12943-020-01215-410.1186/s12943-020-01215-4 ↗
42. 10.1016/j.jbspin.2016.02.01610.1016/j.jbspin.2016.02.016 ↗
43. 10.1093/rheumatology/kex28710.1093/rheumatology/kex287 ↗
44. 10.1002/jor.2458010.1002/jor.24580 ↗
45. 10.1093/nar/gkab53810.1093/nar/gkab538 ↗
46. 10.1038/s41416-019-0566-710.1038/s41416-019-0566-7 ↗